Fig. 7From: Identification and validation of a gene-based signature reveals SLC25A10 as a novel prognostic indicator for patients with ovarian cancerThe sensitivity analysis of SLC25A10 and multiple chemotherapeutic drugs. The top 16 drugs with high correlation with SLC25A10 expression were demonstratedBack to article page